Japan Health Ministry To Review Study Exonerating Tamiflu
This article was originally published in PharmAsia News
Japan's Health Ministry is expected to cancel a warning it had ordered on Roche's Tamiflu (oseltamivir) for teenagers after a study found no link to mental problems. The government-funded study completed by an Osaka City University professor found that children given the flu vaccine did not demonstrate psychotic behavior beyond normal levels. The ministry will use the study for a report of its own and a review of it by its drug safety committee, according to a ministry official. Tamiflu was required to carry the warning label after reports of psychotic behavior among youth under the age of 18 who had received the drug. (Click here for more
You may also be interested in...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.